Hemostats Market CAGR is expected to be 6.5% during the forecast period and the market size is expected to reach nearly US$ 4.28 Bn. by 2029. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.To know about the Research Methodology :- Request Free Sample Report The hemostat is also known as hemostat clamp or arterial forceps. It is a surgical tool that is used during minimally invasive surgical procedures in order to control blood loss or halt bleeding during surgery. It is essentially used in the early phases of surgery for an initial incision that closes blood vessels until ligation. Hemostats market is segmented by product, application, formulation, and region. Among products, thrombin-based hemostats segment market accounted for the xx% share in 2021 due to its high adoption of innovative products and advanced technology. Chronic conditions and aging population leading to increase in the number of surgical procedures, technological advancements, the increasing number of minimally invasive surgeries, and improving healthcare spending would drive the market growth rate of hemostats. In addition, it has lucrative growth opportunities due to unmet medical needs and emerging healthcare market conditions. However, a reluctance of surgeons towards new products and weak reimbursement may hamper the market growth. Based on applications, orthopedic surgery and neurological surgery segment are expected to be some of the major and fastest growing segments in the forecast period due to rising adoption of minimally invasive surgeries and rise in regulated clinical procedures of old people. Among regions, the North America is expected to grow at the xx% CAGR during the forecast period due to a large number of surgeries performed in the region as well as the development of technologically advanced products for achieving blood control during trauma-related procedures. The Asia Pacific is expected to grow at the xx% CAGR during the forecast period due to an increasing number of surgeries, technological advancements, chronic condition, and improvement in healthcare access. The production players focus on mergers and collaborations, strategic partnerships, as well as innovative technological product launches to expand their business product portfolio as main strategies. In the Hemostats market, Baxter International, Inc. (US), holds the leadership position due to advancing surgical innovation, production capacity expansion, brand portfolio expansion, mergers, collaborations, and acquisitions. In 2018, the company has adopted new product launches, product enhancements, and geographic expansion as its crucial business plans to certify its dominance in this market. The objective of the report is to present comprehensive analysis of Hemostats market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Hemostats market dynamics, structure by analyzing the market segments, and project the Hemostats market size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Hemostats market make the report investor’s guide.
Hemostats Market Scope: Inquire before buying
Global Hemostats Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2018 to 2022 Market Size in 2021: US $ 2.59 Bn. Forecast Period 2022 to 2029 CAGR: 6.5% Market Size in 2029: US $ 4.28 Bn. Segments Covered: by Product Thrombin-based hemostats Oxidized regenerated cellulose based hemostats Combination hemostats Gelatin-based hemostatsCollagen-based hemostats by Application Orthopedic surgery General surgery Neurological surgery Cardiovascular surgery Reconstructive surgery Gynecological surgery Other surgeries by Formulation Matrix & gel hemostats Sheet & pad hemostats Sponge hemostats Powder hemostats Hemostats Market, by Region:
North America (United States, Canada and Mexico) Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest)Key Players:
1.CR Bard, Inc. 2.Ethicon, Inc. 3.Braun Melsungen AG 4.Teleflex 5.Baxter International, Inc. 6.Integra LifeSciences 7.Marine Polymer Technologies, Inc. 8.Pfizer, Inc. 9.Z-Medica LLC 10.Gelita Medical GmbH 11.3-D Matrix Medical Technology 12.RESORBA Medical GmbH, Anika Therapeutics, Inc., 13.Arch Therapeutics, Inc., 14.Biom'up SAS, CryoLife, Inc. 15.Gamma Therapeutics, Inc. 16.MedTrade Products Limited 17.Integra LifeSciences 18.Medline Industries, Inc 19.HEMOTEC MEDICAL GMBH, 20.Stryker, 21.CSL 22.Mallinckrodt 23.Equimedica Frequently Asked Questions: 1. Which region has the largest share in Global Hemostats Market? Ans: North America region holds the highest share in 2021. 2. What is the growth rate of Global Hemostats Market? Ans: The Global Hemostats Market is growing at a CAGR of 6.5% during forecasting period 2022-2029. 3. What is scope of the Global Hemostats market report? Ans: Global Hemostats Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Hemostats market? Ans: The important key players in the Global Hemostats Market are – CR Bard, Inc., Ethicon, Inc., Braun Melsungen AG, Teleflex, Baxter International, Inc., Integra LifeSciences, Marine Polymer Technologies, Inc., Pfizer, Inc., Z-Medica LLC, Gelita Medical GmbH, 3-D Matrix Medical Technology, RESORBA Medical GmbH, Anika Therapeutics, Inc.,, Arch Therapeutics, Inc.,, Biom'up SAS, CryoLife, Inc., Gamma Therapeutics, Inc., MedTrade Products Limited, Integra LifeSciences, Medline Industries, Inc, HEMOTEC MEDICAL GMBH,, Stryker,, CSL, Mallinckrodt, and Equimedica 5. What is the study period of this market? Ans: The Global Hemostats Market is studied from 2021 to 2029.
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Hemostats Market Size, by Market Value (US$ Bn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Hemostats Market Analysis and Forecast 5.1. Global Hemostats Market Analysis and Forecast 5.2. Global Hemostats Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Hemostats Market Analysis and Forecast, by Product 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Hemostats Market Value Share Analysis, by Product 6.4. Market Size (US$ Bn) Forecast, by Product 6.5. Global Hemostats Market Analysis, by Product 6.6. Hemostats Market Attractiveness Analysis, by Product 7. Global Hemostats Market Analysis and Forecast, by Application 7.1. Introduction and Definition 7.2. Global Hemostats Market Value Share Analysis, by Application 7.3. Market Size (US$ Bn) Forecast, by Application 7.4. Global Hemostats Market Analysis, by Application 7.5. Global Hemostats Market Attractiveness Analysis, by Application 8. Global Hemostats Market Analysis and Forecast, by Formulation 8.1. Introduction and Definition 8.2. Global Hemostats Market Value Share Analysis, by Formulation 8.3. Market Size (US$ Bn) Forecast, by Formulation 8.4. Global Hemostats Market Analysis, by Formulation 8.5. Global Hemostats Market Attractiveness Analysis, by Formulation 9. Global Hemostats Market Analysis, by Region 9.1. Global Hemostats Market Value Share Analysis, by Region 9.2. Market Size (US$ Bn) Forecast, by Region 9.3. Global Hemostats Market Attractiveness Analysis, by Region 10. North America Hemostats Market Analysis 10.1. Key Findings 10.2. North America Hemostats Market Overview 10.3. North America Hemostats Market Value Share Analysis, by Product 10.4. North America Hemostats Market Forecast, by Product 10.4.1. Thrombin-based hemostats 10.4.2. Oxidized regenerated cellulose based hemostats 10.4.3. Combination hemostats 10.4.4. Gelatin-based hemostats 10.4.5. Collagen-based hemostats 10.5. North America Hemostats Market Value Share Analysis, by Application 10.6. North America Hemostats Market Forecast, by Application 10.6.1. Orthopedic surgery 10.6.2. General surgery 10.6.3. Neurological surgery 10.6.4. Cardiovascular surgery 10.6.5. Reconstructive surgery 10.6.6. Gynecological surgery 10.6.7. Other surgeries 10.7. North America Hemostats Market Value Share Analysis, by Formulation 10.8. North America Hemostats Market Forecast, by Formulation 10.8.1. Matrix & gel hemostats 10.8.2. Sheet & pad hemostats 10.8.3. Sponge hemostats 10.8.4. Powder hemostats 10.9. North America Hemostats Market Value Share Analysis, by Country 10.10. North America Hemostats Market Forecast, by Country 10.10.1.1. U.S., 2018–2026 10.10.1.2. Canada, 2018–2026 10.11. North America Hemostats Market Analysis, by Country 10.12. U.S. Hemostats Market Forecast, by Product 10.12.1. On-premises 10.12.2. Cloud 10.13. U.S. Hemostats Market Forecast, by Application 10.13.1. Orthopedic surgery 10.13.2. General surgery 10.13.3. Neurological surgery 10.13.4. Cardiovascular surgery 10.13.5. Reconstructive surgery 10.13.6. Gynecological surgery 10.13.7. Other surgeries 10.14. U.S. Hemostats Market Forecast, by Formulation 10.14.1. Matrix & gel hemostats 10.14.2. Sheet & pad hemostats 10.14.3. Sponge hemostats 10.14.4. Powder hemostats 10.15. Canada Hemostats Market Forecast, by Product 10.15.1. Thrombin-based hemostats 10.15.2. Oxidized regenerated cellulose based hemostats 10.15.3. Combination hemostats 10.15.4. Gelatin-based hemostats 10.15.5. Collagen-based hemostats 10.16. Canada Hemostats Market Forecast, by Application 10.16.1. Orthopedic surgery 10.16.2. General surgery 10.16.3. Neurological surgery 10.16.4. Cardiovascular surgery 10.16.5. Reconstructive surgery 10.16.6. Gynecological surgery 10.16.7. Other surgeries 10.17. Canada Hemostats Market Forecast, by Formulation 10.17.1. Matrix & gel hemostats 10.17.2. Sheet & pad hemostats 10.17.3. Sponge hemostats 10.17.4. Powder hemostats 10.18. North America Hemostats Market Attractiveness Analysis 10.18.1. By Product 10.18.2. By Application 10.18.3. By Formulation 10.19. PEST Analysis 11. Europe Hemostats Market Analysis 11.1. Key Findings 11.2. Europe Hemostats Market Overview 11.3. Europe Hemostats Market Value Share Analysis, by Product 11.4. Europe Hemostats Market Forecast, by Product 11.4.1. Thrombin-based hemostats 11.4.2. Oxidized regenerated cellulose based hemostats 11.4.3. Combination hemostats 11.4.4. Gelatin-based hemostats 11.4.5. Collagen-based hemostats 11.5. Europe Hemostats Market Value Share Analysis, by Application 11.6. Europe Hemostats Market Forecast, by Application 11.6.1. Orthopedic surgery 11.6.2. General surgery 11.6.3. Neurological surgery 11.6.4. Cardiovascular surgery 11.6.5. Reconstructive surgery 11.6.6. Gynecological surgery 11.6.7. Other surgeries 11.7. Europe Hemostats Market Value Share Analysis, by Formulation 11.8. Europe Hemostats Market Forecast, by Formulation 11.8.1. Matrix & gel hemostats 11.8.2. Sheet & pad hemostats 11.8.3. Sponge hemostats 11.8.4. Powder hemostats 11.9. Europe Hemostats Market Value Share Analysis, by Country 11.10. Europe Hemostats Market Forecast, by Country 11.10.1.1. Germany 11.10.1.2. U.K. 11.10.1.3. France 11.10.1.4. Italy 11.10.1.5. Spain 11.10.1.6. Rest of Europe 11.11. Europe Hemostats Market Analysis, by Country/ Sub-region 11.12. Germany Hemostats Market Forecast, by Product 11.12.1. On-premises 11.12.2. Cloud 11.13. Germany Hemostats Market Forecast, by Application 11.13.1. Orthopedic surgery 11.13.2. General surgery 11.13.3. Neurological surgery 11.13.4. Cardiovascular surgery 11.13.5. Reconstructive surgery 11.13.6. Gynecological surgery 11.13.7. Other surgeries 11.14. Germany Hemostats Market Forecast, by Formulation 11.14.1. Matrix & gel hemostats 11.14.2. Sheet & pad hemostats 11.14.3. Sponge hemostats 11.14.4. Powder hemostats 11.15. U.K. Hemostats Market Forecast, by Product 11.15.1. Thrombin-based hemostats 11.15.2. Oxidized regenerated cellulose based hemostats 11.15.3. Combination hemostats 11.15.4. Gelatin-based hemostats 11.15.5. Collagen-based hemostats 11.16. U.K. Hemostats Market Forecast, by Application 11.16.1. Orthopedic surgery 11.16.2. General surgery 11.16.3. Neurological surgery 11.16.4. Cardiovascular surgery 11.16.5. Reconstructive surgery 11.16.6. Gynecological surgery 11.16.7. Other surgeries 11.17. U.K. Hemostats Market Forecast, by Formulation 11.17.1. Matrix & gel hemostats 11.17.2. Sheet & pad hemostats 11.17.3. Sponge hemostats 11.17.4. Powder hemostats 11.18. France Hemostats Market Forecast, by Product 11.18.1. Thrombin-based hemostats 11.18.2. Oxidized regenerated cellulose based hemostats 11.18.3. Combination hemostats 11.18.4. Gelatin-based hemostats 11.18.5. Collagen-based hemostats 11.19. France Hemostats Market Forecast, by Application 11.19.1. Orthopedic surgery 11.19.2. General surgery 11.19.3. Neurological surgery 11.19.4. Cardiovascular surgery 11.19.5. Reconstructive surgery 11.19.6. Gynecological surgery 11.19.7. Other surgeries 11.20. France Hemostats Market Forecast, by Formulation 11.20.1. Matrix & gel hemostats 11.20.2. Sheet & pad hemostats 11.20.3. Sponge hemostats 11.20.4. Powder hemostats 11.21. Italy Hemostats Market Forecast, by Product 11.21.1. Thrombin-based hemostats 11.21.2. Oxidized regenerated cellulose based hemostats 11.21.3. Combination hemostats 11.21.4. Gelatin-based hemostats 11.21.5. Collagen-based hemostats 11.22. Italy Hemostats Market Forecast, by Application 11.22.1. Orthopedic surgery 11.22.2. General surgery 11.22.3. Neurological surgery 11.22.4. Cardiovascular surgery 11.22.5. Reconstructive surgery 11.22.6. Gynecological surgery 11.22.7. Other surgeries 11.23. Italy Hemostats Market Forecast, by Formulation 11.23.1. Matrix & gel hemostats 11.23.2. Sheet & pad hemostats 11.23.3. Sponge hemostats 11.23.4. Powder hemostats 11.24. Spain Hemostats Market Forecast, by Product 11.24.1. Thrombin-based hemostats 11.24.2. Oxidized regenerated cellulose based hemostats 11.24.3. Combination hemostats 11.24.4. Gelatin-based hemostats 11.24.5. Collagen-based hemostats 11.25. Spain Hemostats Market Forecast, by Application 11.25.1. Orthopedic surgery 11.25.2. General surgery 11.25.3. Neurological surgery 11.25.4. Cardiovascular surgery 11.25.5. Reconstructive surgery 11.25.6. Gynecological surgery 11.25.7. Other surgeries 11.26. Spain Hemostats Market Forecast, by Formulation 11.26.1. Matrix & gel hemostats 11.26.2. Sheet & pad hemostats 11.26.3. Sponge hemostats 11.26.4. Powder hemostats 11.27. Rest of Europe Hemostats Market Forecast, by Product 11.27.1. Thrombin-based hemostats 11.27.2. Oxidized regenerated cellulose based hemostats 11.27.3. Combination hemostats 11.27.4. Gelatin-based hemostats 11.27.5. Collagen-based hemostats 11.28. Rest of Europe Hemostats Market Forecast, by Application 11.28.1. Orthopedic surgery 11.28.2. General surgery 11.28.3. Neurological surgery 11.28.4. Cardiovascular surgery 11.28.5. Reconstructive surgery 11.28.6. Gynecological surgery 11.28.7. Other surgeries 11.29. Rest of Europe Hemostats Market Forecast, by Formulation 11.29.1. Matrix & gel hemostats 11.29.2. Sheet & pad hemostats 11.29.3. Sponge hemostats 11.29.4. Powder hemostats 11.30. Europe Hemostats Market Attractiveness Analysis 11.30.1. By Product 11.30.2. By Application 11.30.3. By Formulation 11.31. PEST Analysis 12. Asia Pacific Hemostats Market Analysis 12.1. Key Findings 12.2. Asia Pacific Hemostats Market Overview 12.3. Asia Pacific Hemostats Market Value Share Analysis, by Product 12.4. Asia Pacific Hemostats Market Forecast, by Product 12.4.1. Thrombin-based hemostats 12.4.2. Oxidized regenerated cellulose based hemostats 12.4.3. Combination hemostats 12.4.4. Gelatin-based hemostats 12.4.5. Collagen-based hemostats 12.5. Asia Pacific Hemostats Market Value Share Analysis, by Application 12.6. Asia Pacific Hemostats Market Forecast, by Application 12.6.1. Orthopedic surgery 12.6.2. General surgery 12.6.3. Neurological surgery 12.6.4. Cardiovascular surgery 12.6.5. Reconstructive surgery 12.6.6. Gynecological surgery 12.6.7. Other surgeries 12.7. Asia Pacific Hemostats Market Value Share Analysis, by Formulation 12.8. Asia Pacific Hemostats Market Forecast, by Formulation 12.8.1. Matrix & gel hemostats 12.8.2. Sheet & pad hemostats 12.8.3. Sponge hemostats 12.8.4. Powder hemostats 12.9. Asia Pacific Hemostats Market Value Share Analysis, by Country 12.10. Asia Pacific Hemostats Market Forecast, by Country 12.10.1. China, 2018–2026 12.10.2. India, 2018–2026 12.10.3. Japan, 2018–2026 12.10.4. ASEAN, 2018–2026 12.10.5. Rest of Asia Pacific, 2018–2026 12.11. Asia Pacific Hemostats Market Analysis, by Country/ Sub-region 12.12. China Hemostats Market Forecast, by Product 12.12.1. Thrombin-based hemostats 12.12.2. Oxidized regenerated cellulose based hemostats 12.12.3. Combination hemostats 12.12.4. Gelatin-based hemostats 12.12.5. Collagen-based hemostats 12.13. China Hemostats Market Forecast, by Application 12.13.1. Orthopedic surgery 12.13.2. General surgery 12.13.3. Neurological surgery 12.13.4. Cardiovascular surgery 12.13.5. Reconstructive surgery 12.13.6. Gynecological surgery 12.13.7. Other surgeries 12.14. China Hemostats Market Forecast, by Formulation 12.14.1. Matrix & gel hemostats 12.14.2. Sheet & pad hemostats 12.14.3. Sponge hemostats 12.14.4. Powder hemostats 12.15. India Hemostats Market Forecast, by Product 12.15.1. Orthopedic surgery 12.15.2. General surgery 12.15.3. Neurological surgery 12.15.4. Cardiovascular surgery 12.15.5. Reconstructive surgery 12.15.6. Gynecological surgery 12.15.7. Other surgeries 12.16. India Hemostats Market Forecast, by Application 12.16.1. Small & Medium Enterprises 12.16.2. Large Enterprises 12.17. India Hemostats Market Forecast, by Formulation 12.17.1. Matrix & gel hemostats 12.17.2. Sheet & pad hemostats 12.17.3. Sponge hemostats 12.17.4. Powder hemostats 12.18. Japan Hemostats Market Forecast, by Product 12.18.1. Thrombin-based hemostats 12.18.2. Oxidized regenerated cellulose based hemostats 12.18.3. Combination hemostats 12.18.4. Gelatin-based hemostats 12.18.5. Collagen-based hemostats 12.19. Japan Hemostats Market Forecast, by Application 12.19.1. Orthopedic surgery 12.19.2. General surgery 12.19.3. Neurological surgery 12.19.4. Cardiovascular surgery 12.19.5. Reconstructive surgery 12.19.6. Gynecological surgery 12.19.7. Other surgeries 12.20. Japan Hemostats Market Forecast, by Formulation 12.20.1. Matrix & gel hemostats 12.20.2. Sheet & pad hemostats 12.20.3. Sponge hemostats 12.20.4. Powder hemostats 12.21. ASEAN Hemostats Market Forecast, by Product 12.21.1. Thrombin-based hemostats 12.21.2. Oxidized regenerated cellulose based hemostats 12.21.3. Combination hemostats 12.21.4. Gelatin-based hemostats 12.21.5. Collagen-based hemostats 12.22. ASEAN Hemostats Market Forecast, by Application 12.22.1. Orthopedic surgery 12.22.2. General surgery 12.22.3. Neurological surgery 12.22.4. Cardiovascular surgery 12.22.5. Reconstructive surgery 12.22.6. Gynecological surgery 12.22.7. Other surgeries 12.23. ASEAN Hemostats Market Forecast, by Formulation 12.23.1. Matrix & gel hemostats 12.23.2. Sheet & pad hemostats 12.23.3. Sponge hemostats 12.23.4. Powder hemostats 12.24. Rest of Asia Pacific Hemostats Market Forecast, by Product 12.24.1. Thrombin-based hemostats 12.24.2. Oxidized regenerated cellulose based hemostats 12.24.3. Combination hemostats 12.24.4. Gelatin-based hemostats 12.24.5. Collagen-based hemostats 12.25. Rest of Asia Pacific Hemostats Market Forecast, by Application 12.25.1. Orthopedic surgery 12.25.2. General surgery 12.25.3. Neurological surgery 12.25.4. Cardiovascular surgery 12.25.5. Reconstructive surgery 12.25.6. Gynecological surgery 12.25.7. Other surgeries 12.26. Rest of Asia Pacific Hemostats Market Forecast, by Formulation 12.26.1. Matrix & gel hemostats 12.26.2. Sheet & pad hemostats 12.26.3. Sponge hemostats 12.26.4. Powder hemostats 12.27. Asia Pacific Hemostats Market Attractiveness Analysis 12.27.1. By Product 12.27.2. By Application 12.27.3. By Formulation 12.28. PEST Analysis 13. Middle East & Africa Hemostats Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Hemostats Market Overview 13.3. Middle East & Africa Hemostats Market Value Share Analysis, by Product 13.4. Middle East & Africa Hemostats Market Forecast, by Product 13.4.1. Thrombin-based hemostats 13.4.2. Oxidized regenerated cellulose based hemostats 13.4.3. Combination hemostats 13.4.4. Gelatin-based hemostats 13.4.5. Collagen-based hemostats 13.5. Middle East & Africa Hemostats Market Value Share Analysis, by Application 13.6. Middle East & Africa Hemostats Market Forecast, by Application 13.6.1. Orthopedic surgery 13.6.2. General surgery 13.6.3. Neurological surgery 13.6.4. Cardiovascular surgery 13.6.5. Reconstructive surgery 13.6.6. Gynecological surgery 13.6.7. Other surgeries 13.7. Middle East & Africa Hemostats Market Value Share Analysis, by Formulation 13.8. Middle East & Africa Hemostats Market Forecast, by Formulation 13.8.1. Matrix & gel hemostats 13.8.2. Sheet & pad hemostats 13.8.3. Sponge hemostats 13.8.4. Powder hemostats 13.9. Middle East & Africa Hemostats Market Value Share Analysis, by Country 13.10. Middle East & Africa Hemostats Market Forecast, by Country 13.10.1. GCC, 2018–2026 13.10.2. South Africa, 2018–2026 13.10.3. Rest of Middle East & Africa, 2018–2026 13.11. Middle East & Africa Hemostats Market Analysis, by Country/ Sub-region 13.12. GCC Hemostats Market Forecast, by Product 13.12.1. Thrombin-based hemostats 13.12.2. Oxidized regenerated cellulose based hemostats 13.12.3. Combination hemostats 13.12.4. Gelatin-based hemostats 13.12.5. Collagen-based hemostats 13.13. GCC Hemostats Market Forecast, by Application 13.13.1. Orthopedic surgery 13.13.2. General surgery 13.13.3. Neurological surgery 13.13.4. Cardiovascular surgery 13.13.5. Reconstructive surgery 13.13.6. Gynecological surgery 13.13.7. Other surgeries 13.14. GCC Hemostats Market Forecast, by Formulation 13.14.1. Matrix & gel hemostats 13.14.2. Sheet & pad hemostats 13.14.3. Sponge hemostats 13.14.4. Powder hemostats 13.15. South Africa Hemostats Market Forecast, by Product 13.15.1. Thrombin-based hemostats 13.15.2. Oxidized regenerated cellulose based hemostats 13.15.3. Combination hemostats 13.15.4. Gelatin-based hemostats 13.15.5. Collagen-based hemostats 13.16. South Africa Hemostats Market Forecast, by Application 13.16.1. Orthopedic surgery 13.16.2. General surgery 13.16.3. Neurological surgery 13.16.4. Cardiovascular surgery 13.16.5. Reconstructive surgery 13.16.6. Gynecological surgery 13.16.7. Other surgeries 13.17. South Africa Hemostats Market Forecast, by Formulation 13.17.1. Matrix & gel hemostats 13.17.2. Sheet & pad hemostats 13.17.3. Sponge hemostats 13.17.4. Powder hemostats 13.18. Rest of Middle East & Africa Hemostats Market Forecast, by Product 13.18.1. Thrombin-based hemostats 13.18.2. Oxidized regenerated cellulose based hemostats 13.18.3. Combination hemostats 13.18.4. Gelatin-based hemostats 13.18.5. Collagen-based hemostats 13.19. Rest of Middle East & Africa Hemostats Market Forecast, by Application 13.19.1. Orthopedic surgery 13.19.2. General surgery 13.19.3. Neurological surgery 13.19.4. Cardiovascular surgery 13.19.5. Reconstructive surgery 13.19.6. Gynecological surgery 13.19.7. Other surgeries 13.20. Rest of Middle East & Africa Hemostats Market Forecast, by Formulation 13.20.1. Matrix & gel hemostats 13.20.2. Sheet & pad hemostats 13.20.3. Sponge hemostats 13.20.4. Powder hemostats 13.21. Middle East & Africa Hemostats Market Attractiveness Analysis 13.21.1. By Product 13.21.2. By Application 13.21.3. By Formulation 13.22. PEST Analysis 14. Latin America Hemostats Market Analysis 14.1. Key Findings 14.2. Latin America Hemostats Market Overview 14.3. Latin America Hemostats Market Value Share Analysis, by Product 14.4. Latin America Hemostats Market Forecast, by Product 14.4.1. Thrombin-based hemostats 14.4.2. Oxidized regenerated cellulose based hemostats 14.4.3. Combination hemostats 14.4.4. Gelatin-based hemostats 14.4.5. Collagen-based hemostats 14.5. Latin America Hemostats Market Value Share Analysis, by Application 14.6. Latin America Hemostats Market Forecast, by Application 14.6.1. Orthopedic surgery 14.6.2. General surgery 14.6.3. Neurological surgery 14.6.4. Cardiovascular surgery 14.6.5. Reconstructive surgery 14.6.6. Gynecological surgery 14.6.7. Other surgeries 14.7. Latin America Hemostats Market Value Share Analysis, by Formulation 14.8. Latin America Hemostats Market Forecast, by Formulation 14.8.1. Matrix & gel hemostats 14.8.2. Sheet & pad hemostats 14.8.3. Sponge hemostats 14.8.4. Powder hemostats 14.9. Latin America Hemostats Market Value Share Analysis, by Country 14.10. Latin America Hemostats Market Forecast, by Country 14.10.1.1. Brazil, 2018–2026 14.10.1.2. Mexico, 2018–2026 14.10.1.3. Rest of Latin America, 2018–2026 14.11. Latin America Hemostats Market Analysis, by Country/ Sub-region 14.12. Brazil Hemostats Market Forecast, by Product 14.12.1. Thrombin-based hemostats 14.12.2. Oxidized regenerated cellulose based hemostats 14.12.3. Combination hemostats 14.12.4. Gelatin-based hemostats 14.12.5. Collagen-based hemostats 14.13. Brazil Hemostats Market Forecast, by Application 14.13.1. Orthopedic surgery 14.13.2. General surgery 14.13.3. Neurological surgery 14.13.4. Cardiovascular surgery 14.13.5. Reconstructive surgery 14.13.6. Gynecological surgery 14.13.7. Other surgeries 14.14. Brazil Hemostats Market Forecast, by Formulation 14.14.1. Matrix & gel hemostats 14.14.2. Sheet & pad hemostats 14.14.3. Sponge hemostats 14.14.4. Powder hemostats 14.15. Mexico Hemostats Market Forecast, by Product 14.15.1. Thrombin-based hemostats 14.15.2. Oxidized regenerated cellulose based hemostats 14.15.3. Combination hemostats 14.15.4. Gelatin-based hemostats 14.15.5. Collagen-based hemostats 14.16. Mexico Hemostats Market Forecast, by Application 14.16.1. Orthopedic surgery 14.16.2. General surgery 14.16.3. Neurological surgery 14.16.4. Cardiovascular surgery 14.16.5. Reconstructive surgery 14.16.6. Gynecological surgery 14.16.7. Other surgeries 14.17. Mexico Hemostats Market Forecast, by Formulation 14.17.1. Matrix & gel hemostats 14.17.2. Sheet & pad hemostats 14.17.3. Sponge hemostats 14.17.4. Powder hemostats 14.18. Rest of Latin America Hemostats Market Forecast, by Product 14.18.1. Thrombin-based hemostats 14.18.2. Oxidized regenerated cellulose based hemostats 14.18.3. Combination hemostats 14.18.4. Gelatin-based hemostats 14.18.5. Collagen-based hemostats 14.19. Rest of Latin America Hemostats Market Forecast, by Application 14.19.1. Orthopedic surgery 14.19.2. General surgery 14.19.3. Neurological surgery 14.19.4. Cardiovascular surgery 14.19.5. Reconstructive surgery 14.19.6. Gynecological surgery 14.19.7. Other surgeries 14.20. Rest of Latin America Hemostats Market Forecast, by Formulation 14.20.1. Matrix & gel hemostats 14.20.2. Sheet & pad hemostats 14.20.3. Sponge hemostats 14.20.4. Powder hemostats 14.21. Latin America Hemostats Market Attractiveness Analysis 14.21.1. By Product 14.21.2. By Application 14.21.3. By Formulation 14.22. PEST Analysis 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Company Profiles: Key Players 15.3.1. CR Bard, Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Business Strategy 15.3.1.4. Recent Developments 15.3.1.5. Manufacturing Footprint 15.3.2. Ethicon, Inc. 15.3.3. Braun Melsungen AG 15.3.4. Teleflex 15.3.5. Baxter International, Inc. 15.3.6. Integra LifeSciences 15.3.7. Marine Polymer Technologies, Inc. 15.3.8. Pfizer, Inc. 15.3.9. Z-Medica LLC 15.3.10. Gelita Medical GmbH 15.3.11. 3-D Matrix Medical Technology 15.3.12. RESORBA Medical GmbH, Anika Therapeutics, Inc., 15.3.13. Arch Therapeutics, Inc., 15.3.14. Biom'up SAS, CryoLife, Inc. 15.3.15. Gamma Therapeutics, Inc. 15.3.16. MedTrade Products Limited 15.3.17. Integra LifeSciences 15.3.18. Medline Industries, Inc 15.3.19. HEMOTEC MEDICAL GMBH, 15.3.20. Stryker, 15.3.21. CSL 15.3.22. Mallinckrodt 15.3.23. Equimedica 16. Primary Key Insights